Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial - The Lancet Diabetes & Endocrinology

Biomedicines, Free Full-Text

PDF) Traditional Chinese medicine in thyroid-associated orbitopathy

Recent advances in graves ophthalmopathy medical therapy: a

Proposal for Standardization of Primary and Secondary Outcomes in

Current concepts regarding Graves' orbitopathy - Bartalena - 2022

PDF) Management of Thyroid Eye Disease: A Consensus Statement by

Statin Use Associated with Lower Incidence of Developing Thyroid

Efficacy and safety of osilodrostat in patients with Cushing's

Rosuvastatin in the Primary Prevention of Cardiovascular Disease

Current concepts regarding Graves' orbitopathy - Bartalena - 2022

Management of thyroid eye disease: a Consensus Statement by the

Effect of dapagliflozin on the rate of decline in kidney function